$338.81
Price
$37.5B
Market Cap
664.3
P/E Ratio
53.4
Forward P/E
$0.51
EPS (TTM)
—
Dividend Yield
$4.0B
Cash
$1.1B
Total Debt
102M
Shares Out
$196.45
$385.22
52-Week Range
Institutional Ownership of BEONE MEDICINES LTD-ADR
|
Fund / Manager
Click to search
|
Shares | Value | % of Portfolio | Cost Basis | Est. Return |
|---|---|---|---|---|---|
| No funds currently hold this stock. | |||||
Trading Activity for BEONE MEDICINES LTD-ADR
|
Fund / Manager
Click to search
|
Action | Change | Shares After | Value | Price |
|---|---|---|---|---|---|
| No activity found for this stock. | |||||
Insider Trading for BEONE MEDICINES LTD-ADR
6 Months Insider Sentiment
Buy $0
Sell $58.4M
0
Buys
61
Sells
-58.4M
Net
5
Grants
Largest
$5.1M
Oyler
$4.4M
Oyler
$4.1M
Oyler
| Date |
Insider
Click to search
|
Role
Click to search
|
Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Jan 07, 2026 | Chan Henry Lee | SVP, General Counsel | EXERCISE | 196 | $159.03 | $31K |
| Jan 07, 2026 | Chan Henry Lee | SVP, General Counsel | SELL | 664 | $331.76 | $220K |
| Jan 07, 2026 | Chan Henry Lee | SVP, General Counsel | EXERCISE | 266 | $213.32 | $57K |
| Jan 07, 2026 | Chan Henry Lee | SVP, General Counsel | EXERCISE | 202 | $194.47 | $39K |
| Dec 31, 2025 | Lai Wang | President, Global Head of R&D | GRANT | 427.9K | — | — |
| Dec 16, 2025 | John Oyler | Chief Executive Officer | SELL | 2.6K | $301.79 | $775K |
| Dec 16, 2025 | John Oyler | Chief Executive Officer | SELL | 2.0K | $304.36 | $601K |
| Dec 16, 2025 | John Oyler | Chief Executive Officer | SELL | 1.9K | $300.80 | $565K |
| Dec 16, 2025 | John Oyler | Chief Executive Officer | SELL | 1.6K | $303.13 | $495K |
| Dec 16, 2025 | John Oyler | Chief Executive Officer | SELL | 1.5K | $302.31 | $457K |
| Dec 16, 2025 | John Oyler | Chief Executive Officer | SELL | 1.3K | $304.13 | $382K |
| Dec 16, 2025 | John Oyler | Chief Executive Officer | SELL | 40 | $305.24 | $12K |
| Dec 16, 2025 | John Oyler | Chief Executive Officer | SELL | 600 | $300.98 | $181K |
| Dec 16, 2025 | John Oyler | Chief Executive Officer | SELL | 7.5K | $302.74 | $2.3M |
| Dec 16, 2025 | John Oyler | Chief Executive Officer | SELL | 5.4K | $303.72 | $1.7M |
| Dec 15, 2025 | John Oyler | Chief Executive Officer | SELL | 3.9K | $305.55 | $1.2M |
| Dec 15, 2025 | John Oyler | Chief Executive Officer | SELL | 1.2K | $314.92 | $376K |
| Dec 15, 2025 | John Oyler | Chief Executive Officer | SELL | 1.8K | $301.58 | $540K |
| Dec 15, 2025 | John Oyler | Chief Executive Officer | SELL | 1.9K | $303.60 | $576K |
| Dec 15, 2025 | John Oyler | Chief Executive Officer | SELL | 2.3K | $311.33 | $730K |
| Dec 15, 2025 | John Oyler | Chief Executive Officer | SELL | 929 | $313.52 | $291K |
| Dec 15, 2025 | John Oyler | Chief Executive Officer | SELL | 4.9K | $306.39 | $1.5M |
| Dec 15, 2025 | John Oyler | Chief Executive Officer | SELL | 16.3K | $310.48 | $5.1M |
| Dec 15, 2025 | John Oyler | Chief Executive Officer | SELL | 14.2K | $308.41 | $4.4M |
| Dec 15, 2025 | John Oyler | Chief Executive Officer | SELL | 10.7K | $309.37 | $3.3M |
| Dec 15, 2025 | John Oyler | Chief Executive Officer | SELL | 6.4K | $302.29 | $1.9M |
| Dec 15, 2025 | John Oyler | Chief Executive Officer | SELL | 5.8K | $304.37 | $1.8M |
| Dec 15, 2025 | John Oyler | Chief Executive Officer | SELL | 5.1K | $307.38 | $1.6M |
| Dec 15, 2025 | John Oyler | Chief Executive Officer | SELL | 121 | $311.93 | $38K |
| Dec 11, 2025 | Chan Henry Lee | SVP, General Counsel | EXERCISE | 98 | $159.03 | $16K |
| Dec 11, 2025 | Chan Henry Lee | SVP, General Counsel | SELL | 332 | $325.00 | $108K |
| Dec 11, 2025 | Chan Henry Lee | SVP, General Counsel | EXERCISE | 133 | $213.32 | $28K |
| Dec 11, 2025 | Chan Henry Lee | SVP, General Counsel | EXERCISE | 101 | $194.47 | $20K |
| Dec 10, 2025 | Chan Henry Lee | SVP, General Counsel | EXERCISE | 98 | $159.03 | $16K |
| Dec 10, 2025 | Chan Henry Lee | SVP, General Counsel | EXERCISE | 133 | $213.32 | $28K |
| Dec 10, 2025 | Chan Henry Lee | SVP, General Counsel | SELL | 332 | $318.28 | $106K |
| Dec 10, 2025 | Chan Henry Lee | SVP, General Counsel | EXERCISE | 101 | $194.47 | $20K |
| Nov 26, 2025 | Corazon (Corsee) D. Sanders | Director | SELL | 1.8K | $340.20 | $620K |
| Nov 26, 2025 | Corazon (Corsee) D. Sanders | Director | SELL | 804 | $342.47 | $275K |
| Nov 26, 2025 | Corazon (Corsee) D. Sanders | Director | EXERCISE | 2.6K | $159.03 | $418K |
| Nov 17, 2025 | Xiaobin Wu | President and COO | SELL | 10 | $382.32 | $4K |
| Nov 17, 2025 | Xiaobin Wu | President and COO | SELL | 826 | $381.19 | $315K |
| Nov 17, 2025 | Xiaobin Wu | President and COO | SELL | 3.2K | $380.23 | $1.2M |
| Nov 13, 2025 | Xiaobin Wu | President and COO | SELL | 1.8K | $381.05 | $674K |
| Nov 13, 2025 | Xiaobin Wu | President and COO | SELL | 4.2K | $380.33 | $1.6M |
| Nov 12, 2025 | Xiaobin Wu | President and COO | SELL | 500 | $350.44 | $175K |
| Nov 12, 2025 | Chan Henry Lee | SVP, General Counsel | EXERCISE | 296 | $159.03 | $47K |
| Nov 12, 2025 | Chan Henry Lee | SVP, General Counsel | EXERCISE | 302 | $194.47 | $59K |
| Nov 12, 2025 | Chan Henry Lee | SVP, General Counsel | EXERCISE | 398 | $213.32 | $85K |
| Nov 12, 2025 | Chan Henry Lee | SVP, General Counsel | SELL | 332 | $350.00 | $116K |
| Nov 12, 2025 | Chan Henry Lee | SVP, General Counsel | SELL | 664 | $348.75 | $232K |
| Nov 12, 2025 | John Oyler | Chief Executive Officer | GRANT | 858.5K | — | — |
| Nov 12, 2025 | Xiaobin Wu | President and COO | SELL | 100 | $357.43 | $36K |
| Nov 12, 2025 | Xiaobin Wu | President and COO | SELL | 120 | $355.00 | $43K |
| Nov 12, 2025 | Xiaobin Wu | President and COO | SELL | 154 | $362.07 | $56K |
| Nov 12, 2025 | Xiaobin Wu | President and COO | SELL | 251 | $354.20 | $89K |
| Nov 12, 2025 | Xiaobin Wu | President and COO | SELL | 789 | $352.78 | $278K |
| Nov 12, 2025 | Xiaobin Wu | President and COO | SELL | 3.2K | $351.41 | $1.1M |
| Nov 12, 2025 | Xiaobin Wu | President and COO | SELL | 4.8K | $360.10 | $1.7M |
| Nov 11, 2025 | John Oyler | Chief Executive Officer | GRANT | 151.3K | — | — |
| Nov 07, 2025 | Xiaodong Wang | Director | GRANT | 424.1K | — | — |
| Oct 08, 2025 | Chan Henry Lee | SVP, General Counsel | SELL | 4.2K | $351.12 | $1.5M |
| Oct 08, 2025 | Chan Henry Lee | SVP, General Counsel | SELL | 1.1K | $350.00 | $389K |
| Oct 08, 2025 | Chan Henry Lee | SVP, General Counsel | SELL | 664 | $347.82 | $231K |
| Oct 08, 2025 | Chan Henry Lee | SVP, General Counsel | EXERCISE | 9.0K | $213.32 | $1.9M |
| Oct 08, 2025 | Chan Henry Lee | SVP, General Counsel | EXERCISE | 302 | $194.47 | $59K |
| Oct 08, 2025 | Chan Henry Lee | SVP, General Counsel | EXERCISE | 296 | $159.03 | $47K |
| Oct 08, 2025 | Chan Henry Lee | SVP, General Counsel | SELL | 4.7K | $350.22 | $1.7M |
| Sep 16, 2025 | John Oyler | Chief Executive Officer | SELL | 4.0K | $326.90 | $1.3M |
| Sep 16, 2025 | John Oyler | Chief Executive Officer | SELL | 400 | $327.78 | $131K |
| Sep 16, 2025 | John Oyler | Chief Executive Officer | SELL | 12.4K | $326.14 | $4.1M |
| Sep 16, 2025 | John Oyler | Chief Executive Officer | SELL | 6.9K | $325.06 | $2.2M |
| Sep 16, 2025 | John Oyler | Chief Executive Officer | SELL | 4.1K | $324.12 | $1.3M |
| Sep 10, 2025 | Chan Henry Lee | SVP, General Counsel | SELL | 300 | $326.80 | $98K |
| Sep 10, 2025 | Chan Henry Lee | SVP, General Counsel | EXERCISE | 6.8K | $194.47 | $1.3M |
| Sep 10, 2025 | Chan Henry Lee | SVP, General Counsel | EXERCISE | 296 | $159.03 | $47K |
| Sep 10, 2025 | Chan Henry Lee | SVP, General Counsel | EXERCISE | 1.8K | $213.32 | $383K |
| Sep 10, 2025 | Chan Henry Lee | SVP, General Counsel | SELL | 1.1K | $325.00 | $361K |
| Sep 10, 2025 | Chan Henry Lee | SVP, General Counsel | SELL | 500 | $327.93 | $164K |
| Sep 10, 2025 | Chan Henry Lee | SVP, General Counsel | SELL | 3.3K | $325.73 | $1.1M |
| Sep 10, 2025 | Chan Henry Lee | SVP, General Counsel | SELL | 4.8K | $325.19 | $1.6M |
| Sep 09, 2025 | Xiaodong Wang | Director | GRANT | 148.1K | — | — |
| Sep 09, 2025 | Lai Wang | Global Head of R&D | SELL | 5.0K | $350.06 | $1.8M |
| Sep 05, 2025 | Corazon (Corsee) D. Sanders | Director | SELL | 2.7K | $337.00 | $898K |
| Sep 05, 2025 | Corazon (Corsee) D. Sanders | Director | EXERCISE | 2.7K | $155.68 | $415K |
| Sep 02, 2025 | Titus B. Ball | Principal Accounting Officer | SELL | 122 | $326.76 | $40K |